Publisher
Springer International Publishing
Reference134 articles.
1. Akone SH, Ntie-Kang F, Stuhldreier F, Ewonkem MB, Noah AM, Mouelle SEM, Müller R (2020) Natural products impacting DNA methyltransferases and histone deacetylases. Front Pharmacol 11:992
2. Atsumi Y, Minakawa Y, Ono M, Dobashi S, Shinohe K, Shinohara A, Takeda S, Takagi M, Takamatsu N, Nakagama H et al (2015) ATM and SIRT6/SNF2H mediate transient H2AX stabilization when DSBs form by blocking HUWE1 to allow efficient γH2AX foci formation. Cell Rep 13:2728–2740
3. Aylott HE, Atkinson SJ, Bamborough P, Bassil A, Chung CW, Gordon L, Grandi P, Gray JRJ, Harrison LA, Hayhow TG et al (2021) Template-hopping approach leads to potent, selective, and highly soluble Bromo and Extraterminal domain (BET) second Bromodomain (BD2) inhibitors. J Med Chem 64:3249–3281
4. Barcena-Varela M, Caruso S, Llerena S, Alvarez-Sola G, Uriarte I, Latasa MU, Urtasun R, Rebouissou S, Alvarez L, Jimenez M et al (2019) Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma. Hepatology 69:587–603
5. Bauer K, Berghoff AS, Preusser M, Heller G, Zielinski CC, Valent P, Grunt TW (2021) Degradation of BRD4–a promising treatment approach not only for hematologic but also for solid cancer. Am J Cancer Res 11:530–545